Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Milagre

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Research|June 3, 2010
A mouse model of melanoma driven by oncogenic KRASCarla Milagre, Nathalie Dhomen, Felipe C Geyer, et al.
Cell|February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAFSonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
Cancer Research|June 18, 2015
Interleukin-6 Stimulates Defective AngiogenesisGanga Gopinathan, Carla Milagre, Oliver M T Pearce, et al.
Pigment Cell & Melanoma Research|March 23, 2011
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progressionJulia K Soo, Alastair D Mackenzie Ross, David M Kallenberg, et al.
Journal of Medicinal Chemistry|April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-CellsJonathan Powell, Filipa Mota, David Steadman, et al.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Research|June 3, 2010
A mouse model of melanoma driven by oncogenic KRASCarla Milagre, Nathalie Dhomen, Felipe C Geyer, et al.
Cell|February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAFSonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
Cancer Research|June 18, 2015
Interleukin-6 Stimulates Defective AngiogenesisGanga Gopinathan, Carla Milagre, Oliver M T Pearce, et al.
Pigment Cell & Melanoma Research|March 23, 2011
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progressionJulia K Soo, Alastair D Mackenzie Ross, David M Kallenberg, et al.
Journal of Medicinal Chemistry|April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-CellsJonathan Powell, Filipa Mota, David Steadman, et al.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Pageof 1